These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1365434)

  • 1. Investigation of the mechanism of glucocorticoid action on dopamine agonist sensitivity.
    Crocker AD; Stanley JE; Cameron DL
    Neurochem Int; 1992 Mar; 20 Suppl():241S-243S. PubMed ID: 1365434
    [No Abstract]   [Full Text] [Related]  

  • 2. Localisation of striatal muscarinic receptors involved in dopamine receptor-mediated behavioural responses.
    Crocker AD; Cameron DL
    Neurosci Lett; 1992 Aug; 142(1):73-6. PubMed ID: 1407723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic neonatal blockade of N-methyl-D-aspartate receptor by CGP 39551 increases dopaminergic function in adult rat.
    Dall'Olio R; Facchinetti F; Contestabile A; Gandolfi O
    Neuroscience; 1994 Nov; 63(2):451-5. PubMed ID: 7891857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cannabinoid CB1 receptor antagonism markedly increases dopamine receptor-mediated stereotypies.
    Ferrer B; Gorriti MA; Palomino A; Gornemann I; de Diego Y; Bermudez-Silva FJ; Bilbao A; Fernandez-Espejo E; Moratalla R; Navarro M; Rodríguez de Fonseca F
    Eur J Pharmacol; 2007 Mar; 559(2-3):180-3. PubMed ID: 17291487
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Different effects on dopamine receptors D1 and D2 following long-term usage of L-dopa].
    Wei D
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1991 Apr; 24(2):104-7, 125. PubMed ID: 1830547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of selective adenosine A1 and A2A receptor agonists on dopamine receptor agonist-induced behavioural responses in rats.
    Rimondini R; Ferré S; Giménez-Llort L; Ogren SO; Fuxe K
    Eur J Pharmacol; 1998 Apr; 347(2-3):153-8. PubMed ID: 9653875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective stimulation of striatal dopamine receptors of the D1- or D2-class causes opposite changes of fos expression in the rat cerebral cortex.
    Blandini F; Fancellu R; Orzi F; Conti G; Greco R; Tassorelli C; Nappi G
    Eur J Neurosci; 2003 Feb; 17(4):763-70. PubMed ID: 12603266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A permanent dopamine receptor up-regulation in the ovariectomized rat.
    Gordon JH; Fields JZ
    Pharmacol Biochem Behav; 1989 May; 33(1):123-5. PubMed ID: 2780771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of glucocorticoid secretion induces a behaviorally depressive state in rotarod performance in rat.
    Mizoguchi K; Ikeda R; Shoji H; Tanaka Y; Tabira T
    Pharmacol Biochem Behav; 2008 Oct; 90(4):730-4. PubMed ID: 18582494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucocorticoids modulate behavioral effects induced by dopaminergic agonists in rats.
    Danilczuk Z; Ossowska G; Wróbel A; Lupina T
    Pol J Pharmacol; 2001; 53(5):467-73. PubMed ID: 11990064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral responsitivity to dopamine receptor agonists after extensive striatal dopamine lesions during development.
    Neal-Beliveau BS; Joyce JN
    Dev Psychobiol; 1998 May; 32(4):313-26. PubMed ID: 9589220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
    Sibley DR; Weinberger S; Segal DS; Creese I
    Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
    [No Abstract]   [Full Text] [Related]  

  • 13. Thiazoloindans and thiazolobenzopyrans: a novel class of orally active central dopamine (partial) agonists.
    van Vliet LA; Rodenhuis N; Wikström H; Pugsley TA; Serpa KA; Meltzer LT; Heffner TG; Wise LD; Lajiness ME; Huff RM; Svensson K; Haenen GR; Bast A
    J Med Chem; 2000 Sep; 43(19):3549-57. PubMed ID: 11000009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of glucocorticoids on dopaminergic transmission in the rat dorsolateral striatum.
    Barrot M; Abrous DN; Marinelli M; Rougé-Pont F; Le Moal M; Piazza PV
    Eur J Neurosci; 2001 Feb; 13(4):812-8. PubMed ID: 11207816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine agonist potencies of ergolines.
    Lew JY; Nakamura S; Battista AF; Goldstein M
    Commun Psychopharmacol; 1979; 3(3):179-83. PubMed ID: 115634
    [No Abstract]   [Full Text] [Related]  

  • 16. D-2 dopamine receptor synthesis and turnover in rat striatum.
    Fukuchi I; Fujita N; Nakahiro M; Saito K; Yoshida H
    Eur J Pharmacol; 1986 Aug; 127(3):291-4. PubMed ID: 2944755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SCH 23390-induced behavioral supersensitivity is not related to striatal c-fos levels.
    Muñoz JE; Marín C; Tolosa E
    Brain Res; 1997 Nov; 774(1-2):51-4. PubMed ID: 9452191
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined intrastriatal dopamine D1 and serotonin 5-HT2 receptor stimulation reveals a mechanism for hyperlocomotion in 6-hydroxydopamine-lesioned rats.
    Bishop C; Walker PD
    Neuroscience; 2003; 121(3):649-57. PubMed ID: 14568025
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of adrenalectomy and glucocorticoids on rat brain dopamine receptors.
    Biron D; Dauphin C; Di Paolo T
    Neuroendocrinology; 1992 Apr; 55(4):468-76. PubMed ID: 1314340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New putative selective agonists at the D-1 dopamine receptor: behavioural and neurochemical comparison of CY 208-243 with SK&F 101384 and SK&F 103243.
    Murray AM; Waddington JL
    Pharmacol Biochem Behav; 1990 Jan; 35(1):105-10. PubMed ID: 1969161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.